News

Mylan said that following the settlement agreement, it is expected to get the right to market Memantine HCl in the US on January 11, 2015, or earlier, under

Bupropion HCl SR tablets, used in the treatment of major depressive disorder, are the generic equivalent of GlaxoSmithKline’s Wellbutrin SR and are now available from Actavis in the

The study is part of a global collaboration and licensing agreement signed between Merrimack and Sanofi-aventis for MM-121 in 2009. Merrimack said that MM-121 is an antibody that

Oracal trial is a multinational, randomised, double-blind, placebo-controlled Phase III trial designed to enroll about 550 patients. Tarsa Therapeutics also stated that the independent Data Monitoring Committee (DMC)

NicOx was informed by the FDA that the review of the NDA is complete and that it does not approve the Naproxcinod application. FDA has recommended NicOx to

PharmCentre said that its presence along with other locations in US and Philippines offer 24×7 coverage of it’s services to customers. PharmCentre believes that call management plays a

Sigma-Aldrich’s reported and organic sales for specialty fine chemicals (SAFC) increased by 10% and 11% respectively. Research product sales increased by 5% on both a reported and organic

Based on the growth of the clinical research market and the demand for outsourced eClinical services, unithink claimed that it has increased its operations by 50% in the

Akebia is expected to recruit up to 28 patients in AKB-6548 Phase 2a study, to assess the safety, tolerability and pharmacokinetics of a single dose of AKB-6548 in